BioSpace News Archive

Wolters Kluwer, Health today announced that Guthrie, a not-for-profit, integrated health care system in Pennsylvania and New York has selected POC Advisor™ to aid in rapid, accurate detection and treatment of sepsis at its four area hospitals.

The Amyloidosis Research Consortium (“ARC”), a non-profit dedicated to accelerating the development of new and innovative treatments to improve the quality of life for amyloidosis patients, today announced the publication of “Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Amyloidosis” in the journal Circulation: Heart Failure

Today Tivity Health® (Nasdaq: TVTY) announced the results of a new study published in the journal Quality of Life Research, which found that increasing frequency of participation in a fitness program improves physical and mental health for older adults.

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Sarepta securities between September 6, 2017 and August 19, 2019, both dates inclusive.

If You Purchased PROVIGIL®, NUVIGIL®, or Generic Provigil® (Modafinil) a CALIFORNIA ATTORNEY GENERAL Settlement Could Affect You

Sickle Cell disease is a condition that affects people around the world.

Results from pivotal trial showed treatment with SAGE-217 resulted in rapid, clinically meaningful improvement in major depressive disorder (MDD) symptoms across multiple measures and time points

Ocuphire Pharma, Inc. announced that it has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019.

The Hogg Foundation for Mental Health is accepting proposals for the Texas Communities Count initiative, which will support complete count efforts in Texas for the 2020 U.S. Census.

Pulse Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 105,000 shares of Pulse Biosciences common stock to two recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on August 29, 2019.